Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration

The involvement of iron in the pathogenesis of Alzheimer’s disease (AD) may be multifaceted. Besides potentially inducing oxidative damage, the bioavailability of iron may be limited within the central nervous system, creating a functionally iron-deficient state. By comparing staining results from b...

Full description

Bibliographic Details
Main Authors: Steven M. LeVine, Sheila Tsau, Sumedha Gunewardena
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/13/3/511
_version_ 1797613097787064320
author Steven M. LeVine
Sheila Tsau
Sumedha Gunewardena
author_facet Steven M. LeVine
Sheila Tsau
Sumedha Gunewardena
author_sort Steven M. LeVine
collection DOAJ
description The involvement of iron in the pathogenesis of Alzheimer’s disease (AD) may be multifaceted. Besides potentially inducing oxidative damage, the bioavailability of iron may be limited within the central nervous system, creating a functionally iron-deficient state. By comparing staining results from baseline and modified iron histochemical protocols, iron was found to be more tightly bound within cortical sections from patients with high levels of AD pathology compared to subjects with a diagnosis of something other than AD. To begin examining whether the bound iron could cause a functional iron deficiency, a protein-coding gene expression dataset of initial, middle, and advanced stages of AD from olfactory bulb tissue was analyzed for iron-related processes with an emphasis on anemia-related changes in initial AD to capture early pathogenic events. Indeed, anemia-related processes had statistically significant alterations, and the significance of these changes exceeded those for AD-related processes. Other changes in patients with initial AD included the expressions of transcripts with iron-responsive elements and for genes encoding proteins for iron transport and mitochondrial-related processes. In the latter category, there was a decreased expression for the gene encoding pitrilysin metallopeptidase 1 (PITRM1). Other studies have shown that PITRM1 has an altered activity in patients with AD and is associated with pathological changes in this disease. Analysis of a gene expression dataset from PITRM1-deficient or sufficient organoids also revealed statistically significant changes in anemia-like processes. These findings, together with supporting evidence from the literature, raise the possibility that a pathogenic mechanism of AD could be a functional deficiency of iron contributing to neurodegeneration.
first_indexed 2024-03-11T06:51:06Z
format Article
id doaj.art-edcaafbe92e3431c83f9d69ce487d8bd
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-11T06:51:06Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-edcaafbe92e3431c83f9d69ce487d8bd2023-11-17T10:00:54ZengMDPI AGBrain Sciences2076-34252023-03-0113351110.3390/brainsci13030511Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances NeurodegenerationSteven M. LeVine0Sheila Tsau1Sumedha Gunewardena2Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USADepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USADepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USAThe involvement of iron in the pathogenesis of Alzheimer’s disease (AD) may be multifaceted. Besides potentially inducing oxidative damage, the bioavailability of iron may be limited within the central nervous system, creating a functionally iron-deficient state. By comparing staining results from baseline and modified iron histochemical protocols, iron was found to be more tightly bound within cortical sections from patients with high levels of AD pathology compared to subjects with a diagnosis of something other than AD. To begin examining whether the bound iron could cause a functional iron deficiency, a protein-coding gene expression dataset of initial, middle, and advanced stages of AD from olfactory bulb tissue was analyzed for iron-related processes with an emphasis on anemia-related changes in initial AD to capture early pathogenic events. Indeed, anemia-related processes had statistically significant alterations, and the significance of these changes exceeded those for AD-related processes. Other changes in patients with initial AD included the expressions of transcripts with iron-responsive elements and for genes encoding proteins for iron transport and mitochondrial-related processes. In the latter category, there was a decreased expression for the gene encoding pitrilysin metallopeptidase 1 (PITRM1). Other studies have shown that PITRM1 has an altered activity in patients with AD and is associated with pathological changes in this disease. Analysis of a gene expression dataset from PITRM1-deficient or sufficient organoids also revealed statistically significant changes in anemia-like processes. These findings, together with supporting evidence from the literature, raise the possibility that a pathogenic mechanism of AD could be a functional deficiency of iron contributing to neurodegeneration.https://www.mdpi.com/2076-3425/13/3/511Alzheimer’s diseaseanemiahemehistochemistryironmitochondria
spellingShingle Steven M. LeVine
Sheila Tsau
Sumedha Gunewardena
Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration
Brain Sciences
Alzheimer’s disease
anemia
heme
histochemistry
iron
mitochondria
title Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration
title_full Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration
title_fullStr Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration
title_full_unstemmed Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration
title_short Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer’s Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration
title_sort exploring whether iron sequestration within the cns of patients with alzheimer s disease causes a functional iron deficiency that advances neurodegeneration
topic Alzheimer’s disease
anemia
heme
histochemistry
iron
mitochondria
url https://www.mdpi.com/2076-3425/13/3/511
work_keys_str_mv AT stevenmlevine exploringwhetherironsequestrationwithinthecnsofpatientswithalzheimersdiseasecausesafunctionalirondeficiencythatadvancesneurodegeneration
AT sheilatsau exploringwhetherironsequestrationwithinthecnsofpatientswithalzheimersdiseasecausesafunctionalirondeficiencythatadvancesneurodegeneration
AT sumedhagunewardena exploringwhetherironsequestrationwithinthecnsofpatientswithalzheimersdiseasecausesafunctionalirondeficiencythatadvancesneurodegeneration